Agilon Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Agilon Health, Inc. on July 21, 2026, covering events occurring on July 17, 2026. The filing addresses the departure of a senior executive and associated compensatory arrangements.
Key Financial Metrics
The filing does not provide general financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to specific severance compensation:
- Cash Severance: $766,063.00 total, payable in installments over twelve months following the separation date.
- Equity Vesting: Continued vesting of transformation equity awards and restricted stock units through April 30, 2027.
Material Changes
The primary material change is the termination of Girish Venkatachaliah, Chief Technology Officer, effective August 1, 2026. This represents a change in senior management and the incurrence of a specific severance liability.
Outlook, Risks, and Unusual Items
Management Commentary and Arrangements:
- Mr. Venkatachaliah will provide transition consulting services from August 1, 2026, through December 31, 2026.
- The consulting engagement is for no additional cash consideration beyond the continued equity vesting described in the severance package.
- The Severance Agreement becomes effective eight days following execution.
- Equity vesting is subject to applicable performance-based vesting requirements.
- The summary of agreements is qualified by reference to the full text filed as Exhibit 10.1.
Key Facts for Investor Verification
- Verify the exact terms of the "transformation equity award" granted in 2025 and the specific performance conditions attached to the continued vesting.
- Review Exhibit 10.1 (Severance Agreement and General Release) for complete legal terms and release conditions.
- Confirm the impact of the CTO departure on the company's technology roadmap and transition plan through December 2026.
- Note that the filing contains no updated financial guidance or operational metrics for the 2026 fiscal year.